-
Mankind Pharma
Will it break the jinx of IPOs priced above 1000 times the face value?
-
Avalon Technologies
Tight IPO pricing, existing shareholders’ abysmal cost of holding and promoters’ indifferent corporate governance practice weigh against capital appreciation prospects
-
Udayshivakumar Infra
Exorbitant remuneration for a family member who has just two years experience exposes the promoter’s intensions
-
Global Surfaces
Will the son-in-law do better than his father-in-law? In-laws’ company Glittek Granites gave its consent in May 2022 for being disclosed as a group company in the offer document but, the consent was revoked by Glittek in February 2023!
-
Divgi TorqTransfer Systems
High profit margin and low equity base warrant higher discounting, though revenue concentration on just one customer and export dependence on China and Russia are fraught with risk.
-
Sah Polymers
Underplaying the Daud Ali-Peacock Industries connection raises serious credibility issues. In the so called `disclosure era’ Sebi has failed to enforce disclosure on promoter’s hidden link!
-
Uniparts India
Fundamentals justify IPO valuation though existing shareholders’ negative cost of holding may curb share prospects post lock-in
-
Dharmaj Crop Guard
Notwithstanding strong fundamentals, Heranba looks more attractive at the current valuation!
-
Keystone Realtors
Popular brand notwithstanding, fluctuating past performance, uncertain future prospects and steep IPO valuation dilute attraction.
-
Inox Green Energy
Prospectus disclosures are not sacrosanct for the Jains of Inox-GFL who have insatiable appetite for public funds!